- Home
- ASB vs SRRK Comparison
ASB vs SRRK Comparison
Compare ASB & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASB | SRRK |
|---|---|---|
| Founded | 1861 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ASB | SRRK |
|---|---|---|
| Price | $27.75 | $46.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | $28.00 | ★ $49.80 |
| AVG Volume (30 Days) | ★ 2.0M | 975.4K |
| Earning Date | 01-22-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.98 | N/A |
| Revenue | ★ $1,097,713,000.00 | N/A |
| Revenue This Year | $57.95 | N/A |
| Revenue Next Year | $10.63 | $20,320.92 |
| P/E Ratio | $27.83 | ★ N/A |
| Revenue Growth | ★ 8.93 | N/A |
| 52 Week Low | $18.32 | $22.71 |
| 52 Week High | $27.58 | $48.28 |
Technical Indicators
Market Signals| Indicator | ASB | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 64.06 | 58.94 |
| Support Level | $25.95 | $43.25 |
| Resistance Level | $27.05 | $46.75 |
| Average True Range (ATR) | 0.69 | 2.35 |
| MACD | 0.10 | 0.12 |
| Stochastic Oscillator | 94.49 | 92.12 |
Price Performance
Historical ComparisonAbout ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.